Could a new oat variety be safe for celiac patients?

NCT ID NCT07515105

Completed Symptom relief Sponsor: Faculty Hospital Kralovske Vinohrady Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a low-immunogenic oat variety called Saul is well-tolerated by adults with celiac disease who are in remission. Forty participants ate 50 grams of gluten-free Saul oat flakes daily for 14 days. Researchers tracked symptoms and blood markers to see if the oats caused any immune reaction or discomfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: certified gluten-free oats of the Saul variety
What this could lead to: If successful, this could show that certain oat varieties are well-tolerated by people with celiac disease, potentially expanding their diet options.
What could go wrong: This is a small, completed study with only 40 participants, so results may not apply to everyone. Oats can still cause reactions in some people with celiac disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

celiac disease ornithine aminotransferase deficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CELIAC DISEASE

Contacts and locations

Locations

Department of Internal Medicine, University Hospital Kralovske Vinohrady, Prague, Czech Republic

Prague, 10034, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.